Matinas Biopharma Holdings Shares Outstanding 2012-2020 | MTNB

Matinas Biopharma Holdings shares outstanding from 2012 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Matinas Biopharma Holdings Annual Shares Outstanding
(Millions of Shares)
2019 145
2018 98
2017 90
2016 58
2015 51
2014 32
2013 19
2012 10
2011
Matinas Biopharma Holdings Quarterly Shares Outstanding
(Millions of Shares)
2020-09-30 199
2020-06-30 198
2020-03-31 192
2019-12-31 145
2019-09-30 157
2019-06-30 143
2019-03-31 117
2018-12-31 98
2018-09-30 95
2018-06-30 94
2018-03-31 94
2017-12-31 90
2017-09-30 92
2017-06-30 92
2017-03-31 85
2016-12-31 58
2016-09-30 58
2016-06-30 58
2016-03-31 57
2015-12-31 51
2015-09-30 57
2015-06-30 56
2015-03-31 36
2014-12-31 32
2014-09-30 32
2014-06-30 32
2014-03-31 32
2013-12-31 19
2013-09-30 15
2013-06-30 10
2013-03-31 10
2012-12-31
2012-09-30
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.213B $0.000B
Matinas BioPharma is a clinical-stage biopharmaceutical company focused on enabling the delivery of life-changing medicines using its LNC platform technology. The Company's proprietary, disruptive technology utilizes lipid nano-crystals which can encapsulate small molecule drugs, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making them safer, more tolerable, less toxic and orally bioavailable. The Company's lead anti-fungal product candidate, MAT2203, utilizes its proprietary lipid nano-crystal formulation technology for the safe and effective delivery of the broad-spectrum fungicidal agent, amphotericin B. Based on the positive patient clinical data reported in 2017, Matinas is preparing for a potential Phase 2 pivotal trial of MAT2203 for prevention of invasive fungal infections in patients with acute lymphoblastic leukemia.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $68.424B 37.40
Takeda Pharmaceutical (TAK) Japan $54.984B 10.08
Astellas Pharma (ALPMY) Japan $29.658B 18.31
Eisai (ESALY) Japan $19.965B 22.15
Catalent (CTLT) United States $17.547B 46.43
Grifols, S.A (GRFS) Spain $10.602B 12.34
Jazz Pharmaceuticals (JAZZ) Ireland $9.037B 15.09
Neurocrine Biosciences (NBIX) United States $8.734B 20.25
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.586B 0.00
Ionis Pharmaceuticals (IONS) United States $7.222B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $7.220B 0.00
IPSEN SA ADR (IPSEY) France $7.154B 0.00
United Therapeutics (UTHR) United States $7.142B 13.87
Evotec AG (EVTCY) Germany $6.162B 416.11
Orion OYJ (ORINY) Finland $5.794B 20.11
Turning Point Therapeutics (TPTX) United States $5.049B 0.00
Sage Therapeutics (SAGE) United States $4.125B 0.00
Nektar Therapeutics (NKTR) United States $4.077B 0.00
PTC Therapeutics (PTCT) United States $4.070B 0.00
ChemoCentryx (CCXI) United States $3.983B 0.00
Tilray (TLRY) Canada $3.890B 0.00
Hypermarcas (HYPMY) Brazil $3.484B 13.75
Cronos Group (CRON) Canada $3.473B 0.00
Revolution Medicines (RVMD) United States $3.115B 0.00
FibroGen (FGEN) United States $3.088B 0.00
Pacira BioSciences (PCRX) United States $2.949B 49.79
Corcept Therapeutics (CORT) United States $2.798B 28.07
Taro Pharmaceutical Industries (TARO) Israel $2.705B 16.75
Xencor (XNCR) United States $2.561B 0.00
AlloVir (ALVR) United States $2.248B 0.00
USANA Health Sciences (USNA) United States $2.088B 17.09
BioCryst Pharmaceuticals (BCRX) United States $1.939B 0.00
Sundial Growers (SNDL) Canada $1.926B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.707B 0.00
ImmunoGen (IMGN) United States $1.670B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.608B 12.65
Translate Bio (TBIO) United States $1.601B 0.00
Endo (ENDP) Ireland $1.588B 2.40
Organogenesis Holdings (ORGO) United States $1.573B 0.00
Heron Therapeutics (HRTX) United States $1.549B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.448B 9.29
Ocular Therapeutix (OCUL) United States $1.315B 0.00
Indivior (INVVY) United States $1.227B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.207B 0.00
Zogenix (ZGNX) United States $1.129B 0.00
Aclaris Therapeutics (ACRS) United States $1.095B 0.00
Trillium Therapeutics (TRIL) Canada $1.056B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.005B 0.00
Radius Health (RDUS) United States $0.971B 0.00
Vectura Group (VEGPF) United Kingdom $0.952B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Aerie Pharmaceuticals (AERI) United States $0.903B 0.00
Karyopharm Therapeutics (KPTI) United States $0.865B 0.00
Esperion Therapeutics (ESPR) United States $0.767B 0.00
Collegium Pharmaceutical (COLL) United States $0.756B 28.62
Chinook Therapeutics (KDNY) United States $0.717B 0.00
VAXART, INC (VXRT) United States $0.697B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.690B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.609B 0.00
Ardelyx (ARDX) United States $0.601B 0.00
KalVista Pharmaceuticals (KALV) United States $0.566B 0.00
Flexion Therapeutics (FLXN) United States $0.566B 0.00
Molecular Templates (MTEM) United States $0.521B 0.00
Jounce Therapeutics (JNCE) United States $0.520B 0.00
Rafael Holdings (RFL) United States $0.511B 0.00
Akebia Therapeutics (AKBA) United States $0.510B 0.00
Siga Technologies (SIGA) United States $0.507B 8.40
Acutus Medical (AFIB) United States $0.496B 0.00
Altimmune (ALT) United States $0.490B 0.00
Harpoon Therapeutics (HARP) United States $0.486B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.476B 0.00
AVITA Medical (RCEL) United States $0.473B 0.00
Summit Therapeutics (SMMT) United States $0.472B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.467B 0.00
PROFOUND MEDICL (PROF) Canada $0.453B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.441B 0.00
DURECT (DRRX) United States $0.412B 0.00
TherapeuticsMD (TXMD) United States $0.390B 0.00
MEI Pharma (MEIP) United States $0.389B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.363B 9.46
Innate Pharma SA (IPHYF) France $0.356B 0.00
VYNE Therapeutics (VYNE) United States $0.343B 0.00
Nature's Sunshine Products (NATR) United States $0.337B 21.68
Redhill Biopharma (RDHL) Israel $0.312B 0.00
Alpine Immune Sciences (ALPN) United States $0.309B 0.00
CASI Pharmaceuticals (CASI) United States $0.270B 0.00
Lannett Co Inc (LCI) United States $0.250B 8.39
Xeris Pharmaceuticals (XERS) United States $0.242B 0.00
CTI BioPharma (CTIC) United States $0.223B 0.00
IMV INC (IMV) Canada $0.217B 0.00
Novan (NOVN) United States $0.207B 0.00
Oncternal Therapeutics (ONCT) United States $0.202B 0.00
Concert Pharmaceuticals (CNCE) United States $0.198B 0.00
Nutriband (NTRB) United States $0.197B 0.00
Onconova Therapeutics (ONTX) United States $0.194B 0.00
Calithera Biosciences (CALA) United States $0.190B 0.00
Jaguar Animal Health (JAGX) United States $0.190B 0.00
OptiNose (OPTN) United States $0.186B 0.00
Taiwan Liposome (TLC) Taiwan $0.182B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.182B 0.00
KemPharm (KMPH) United States $0.182B 0.00
Heat Biologics (HTBX) United States $0.181B 0.00
Infinity Pharmaceuticals (INFI) United States $0.177B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.166B 0.00
Iterum Therapeutics (ITRM) Ireland $0.165B 0.00
Qilian Holding Group (QLI) China $0.164B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.158B 0.00
Champions Oncology (CSBR) United States $0.156B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.154B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.153B 0.00
GlycoMimetics (GLYC) United States $0.153B 0.00
Aziyo Biologics (AZYO) United States $0.150B 0.00
IsoRay (ISR) United States $0.143B 0.00
Aquestive Therapeutics (AQST) United States $0.142B 0.00
MediWound (MDWD) Israel $0.141B 0.00
Genocea Biosciences (GNCA) United States $0.141B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.130B 0.00
Otonomy (OTIC) United States $0.127B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.121B 0.00
Lipocine (LPCN) United States $0.115B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.110B 0.00
Assertio Holdings (ASRT) United States $0.108B 0.00
ProPhase Labs (PRPH) United States $0.099B 0.00
SCYNEXIS (SCYX) United States $0.094B 0.00
Natural Alternatives (NAII) United States $0.092B 24.98
Aptorum Group (APM) Hong Kong, SAR China $0.090B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.089B 0.00
ElectroCore (ECOR) United States $0.089B 0.00
Recro Pharma (REPH) United States $0.086B 0.00
AIM ImmunoTech (AIM) United States $0.085B 0.00
AgeX Therapeutics (AGE) United States $0.084B 0.00
Baudax Bio (BXRX) United States $0.084B 0.00
Brickell Biotech (BBI) United States $0.077B 0.00
PolarityTE (PTE) United States $0.077B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.076B 0.00
India Globalization Capital (IGC) United States $0.074B 0.00
Sigyn Therapeutics (SIGY) United States $0.071B 0.00
Biomerica (BMRA) United States $0.069B 0.00
Addex Therapeutics (ADXN) Switzerland $0.069B 0.00
CV Sciences (CVSI) United States $0.064B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.064B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.062B 0.00
Inhibikase Therapeutics (IKT) United States $0.059B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.057B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 24.61
Plus Therapeutics (PSTV) United States $0.047B 0.00
Regulus Therapeutics (RGLS) United States $0.045B 0.00
Mannatech (MTEX) United States $0.038B 5.64
Neos Therapeutics (NEOS) United States $0.038B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.038B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.036B 0.00
RXi Pharmaceuticals (PHIO) United States $0.036B 0.00
Can-Fite Biopharma (CANF) Israel $0.028B 0.00
China SXT Pharmaceuticals (SXTC) China $0.025B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
Midatech Pharma (MTP) United Kingdom $0.024B 0.00
Cyanotech (CYAN) United States $0.022B 17.75
Bellicum Pharmaceuticals (BLCM) United States $0.019B 0.00
JanOne (JAN) United States $0.017B 0.00
HANCOCK JAFFE (HJLI) United States $0.016B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.014B 0.00
Xenetic Biosciences (XBIO) United States $0.013B 0.00
SHINECO INC (TYHT) China $0.012B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00